MSD Ireland
Elaine Doyle has a diverse range of work experience that spans across various roles and industries. Elaine began their career in 1998 at MSD in the UK as a Clinical Data Manager before transitioning to the role of Business Research Analyst. In 2001, they moved to Dolmen Stockbrokers as an Analyst. In 2002, they joined IMS Health as an Account Manager. Elaine then joined MSD Ireland in 2004 and held various positions, including Business Information Manager, Product Manager (HIV), Customer and Disease Understanding Manager, Healthcare Policy and Market Access Manager, and Associate Director Market Access. From 2020 to 2021, they also served as the Separation Lead for Organon Spin-off. Currently, they hold the position of Patient Access Director at MSD Ireland.
Elaine Doyle completed their education history with a degree in Business Studies from University College Dublin in 1997. Prior to that, they obtained a BSc in Molecular Genetics and Botany from the same university between 1992 and 1996. Elaine's secondary education was at Muckross Park College from 1986 to 1992, where they completed the Leaving Cert.
This person is not in any teams
This person is not in any offices
MSD Ireland
1 followers
For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, emerging animal diseases, and, most recently, Covid-19 — as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.msd-ireland.com